- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cameco Corp. Considering Putting $3-Billion Liquidity Toward Uranium
Financial Post reported Cameco Corp. (TSX:CCO,NYSE:CCJ) could use as much as $3-billion liquidity towards acquiring and developing uranium assets.
Financial Post reported Cameco Corp. (TSX:CCO,NYSE:CCJ) could use as much as $3-billion liquidity towards acquiring and developing uranium assets.
As quoted in the market news:
BMO Capital Markets analyst Edward Sterck ran the numbers, and determined that buying a minority stake in European enrichment company URENCO would be the best move. The deal would make Cameco a more fully integrated nuclear company, as it is not currently involved in enrichment.
URENCO is owned by a group of governments and utilities in Britain, the Netherlands and Germany. All of the owners are studying potential sales, so there is an opportunity to get in.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.